Accu-Chek® CONNECT at School (CATS) Pediatric Study
Public ClinicalTrials.gov record NCT02609633. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This interventional, 6-month post-marketing study is designed to evaluate the change in diabetes-related distress among parents/caregivers of school-age children and adolescents with type 1 diabetes (T1D) who are receiving multiple daily injections (MDI) therapy. Investigational sites will be assigned using cluster randomization, with approximately 10 to 20 children at each site. In order to maintain a true control group for comparison, the investigational sites will be randomly assigned to the Accu-Chek® CONNECT Diabetes Management System (DMS) or usual care/continued use of current DMS devices.
Study identification
- NCT ID
- NCT02609633
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 196 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 28, 2015 (Actual)
- Primary completion
- Jan 20, 2017 (Actual)
- Completion
- Jan 20, 2017 (Actual)
- Last update posted
- May 18, 2018
2015 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pediatric Endocrinology of Phoenix | Phoenix | Arizona | 85053 | — |
| Center of Excellence in Diabetes and Endocrinology | Sacramento | California | 95821 | — |
| Barbara Davis Center for Childhood Diabetes | Aurora | Colorado | 80045 | — |
| Nemours Childrens Hospital | Pensacola | Florida | 32504 | — |
| Tallahassee Memorial Hospital | Tallahassee | Florida | 32308 | — |
| University of South Florida College of Medicine | Tampa | Florida | 33612 | — |
| Pediatric Endocrine Associates | Atlanta | Georgia | 30342 | — |
| Rocky Mountain Diabetes & Osteoporosis Center | Idaho Falls | Idaho | 83404 | — |
| Advocate Center for Pediatric Research | Oak Lawn | Illinois | 60453 | — |
| Indiana University Riley | Carmel | Indiana | 46032 | — |
| Childrens Hospital and Clinics of Minnesota | Saint Paul | Minnesota | 55102 | — |
| Women and Children's Hospital of Buffalo | Buffalo | New York | 14222 | — |
| East Caroline University - Pediatric specialty Care | Greenville | North Carolina | 27834 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02609633, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2018 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02609633 live on ClinicalTrials.gov.